Literature DB >> 21871527

Androgen receptor coregulators: recruitment via the coactivator binding groove.

Dennis J van de Wijngaart1, Hendrikus Jan Dubbink, Martin E van Royen, Jan Trapman, Guido Jenster.   

Abstract

Androgens are key regulators of male sexual differentiation and essential for development and maintenance of male reproductive tissues. The androgens testosterone and dihydrotestosterone mediate their effect by binding to, and activation of the androgen receptor (AR). Upon activation, the AR is able to recognize specific DNA sequences in gene promoters and enhancers from where it recruits coregulators to orchestrate chromatin remodeling and transcription regulation. The number of proteins that bind to the AR has surpassed 200 and many of them enhance (coactivator) or repress (corepressor) its transactivating capacity. For most of these coregulators, their AR binding interface and their exact mode of action still needs to be elucidated, but for some of the more classical coactivators and corepressors, we gained insight in their working mechanisms. Of particular interest are specific sequences (LxxLL and FxxLF-like motifs) in a subset of coactivators that interact with the AR via a coactivator binding groove in the ligand-binding domain. As compared to other steroid receptors, the conformation of the AR coactivator binding pocket is unique and preferentially binds FxxLF-like motifs. This predisposition is expected to contribute to the regulation of specific sets of target genes via recruitment of selected coregulators. This review provides an overview of these (inter)actions with a focus on the unique characteristics of the AR coactivator binding groove.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21871527     DOI: 10.1016/j.mce.2011.08.007

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  39 in total

1.  Evidence for DNA-binding domain--ligand-binding domain communications in the androgen receptor.

Authors:  Christine Helsen; Vanessa Dubois; Annelien Verfaillie; Jacques Young; Mieke Trekels; Renée Vancraenenbroeck; Marc De Maeyer; Frank Claessens
Journal:  Mol Cell Biol       Date:  2012-05-29       Impact factor: 4.272

Review 2.  Biologic and clinical significance of androgen receptor variants in castration resistant prostate cancer.

Authors:  Kathryn E Ware; Mariano A Garcia-Blanco; Andrew J Armstrong; Scott M Dehm
Journal:  Endocr Relat Cancer       Date:  2014-05-23       Impact factor: 5.678

Review 3.  Androgen Receptor Structure, Function and Biology: From Bench to Bedside.

Authors:  Rachel A Davey; Mathis Grossmann
Journal:  Clin Biochem Rev       Date:  2016-02

Review 4.  The role of androgen and androgen receptor in skin-related disorders.

Authors:  Jiann-Jyh Lai; Philip Chang; Kuo-Pao Lai; Lumin Chen; Chawnshang Chang
Journal:  Arch Dermatol Res       Date:  2012-07-25       Impact factor: 3.017

5.  Binding of bisphenol A, bisphenol AF, and bisphenol S on the androgen receptor: Coregulator recruitment and stimulation of potential interaction sites.

Authors:  Lalith Perera; Yin Li; Laurel A Coons; Rene Houtman; Rinie van Beuningen; Bonnie Goodwin; Scott S Auerbach; Christina T Teng
Journal:  Toxicol In Vitro       Date:  2017-07-24       Impact factor: 3.500

6.  Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer.

Authors:  Rosalinda M Savoy; Liqun Chen; Salma Siddiqui; Frank U Melgoza; Blythe Durbin-Johnson; Christiana Drake; Maitreyee K Jathal; Swagata Bose; Thomas M Steele; Benjamin A Mooso; Leandro S D'Abronzo; William H Fry; Kermit L Carraway; Maria Mudryj; Paramita M Ghosh
Journal:  Endocr Relat Cancer       Date:  2015-03-10       Impact factor: 5.678

Review 7.  Androgen receptor: what we know and what we expect in castration-resistant prostate cancer.

Authors:  Zhonglin Cai; Weijie Chen; Jianzhong Zhang; Hongjun Li
Journal:  Int Urol Nephrol       Date:  2018-08-20       Impact factor: 2.370

Review 8.  Targeting transcription factor corepressors in tumor cells.

Authors:  Aristeidis G Vaiopoulos; Ioannis D Kostakis; Kalliopi Ch Athanasoula; Athanasios G Papavassiliou
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

9.  Inhibition of androgen receptor transactivation function by adenovirus type 12 E1A undermines prostate cancer cell survival.

Authors:  Dawei Li; Guimei Tian; Jia Wang; Lisa Y Zhao; Olivia Co; Zoe C Underill; Joe S Mymryk; Frank Claessens; Scott M Dehm; Yehia Daaka; Daiqing Liao
Journal:  Prostate       Date:  2018-07-15       Impact factor: 4.104

10.  DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7.

Authors:  Sue Jin Moon; Byong Chang Jeong; Hwa Jin Kim; Joung Eun Lim; Ghee Young Kwon; Jeong Hoon Kim
Journal:  Oncogene       Date:  2017-12-18       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.